US Senator

Susan Collins 2025-2026 Regular Session - Authored & Sponsored Legislation (Page 7)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB331

Introduced
1/30/25  
Refer
1/30/25  
Report Pass
2/27/25  
Engrossed
3/18/25  
Enrolled
7/8/25  
Passed
7/16/25  
Chaptered
7/17/25  
Chaptered
7/16/25  
Passed
7/17/25  
HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB339

Introduced
1/30/25  
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB380

Introduced
2/4/25  
Rural Obstetrics Readiness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB383

Introduced
2/4/25  
JOBS Act of 2025 Jumpstart Our Businesses by Supporting Students Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB410

Introduced
2/5/25  
Love Lives On Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB43

Introduced
1/9/25  
Skinny Labels, Big Savings ActThis bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:submitting or seeking approval of a skinny label for a generic or biosimilar drug;promoting or commercially marketing a drug with skinny labeling approved by the FDA; ordescribing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.The bill also applies the safe harbor to similar actions under the Public Health Service Act.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB5

Introduced
1/6/25  
Engrossed
1/21/25  
Enrolled
1/23/25  
Passed
1/29/25  
Chaptered
1/29/25  
Laken Riley ActThis bill requires the Department of Homeland Security (DHS) to detain certain non-U.S. nationals (aliens under federal law) who have been arrested for burglary, theft, larceny, or shoplifting. The bill also authorizes states to sue the federal government for decisions or alleged failures related to immigration enforcement.Under this bill, DHS must detain an individual who (1) is unlawfully present in the United States or did not possess the necessary documents when applying for admission; and (2) has been charged with, arrested for, convicted of, or admits to having committed acts that constitute the essential elements of burglary, theft, larceny, or shoplifting.The bill also authorizes state governments to sue for injunctive relief over certain immigration-related decisions or alleged failures by the federal government if the decision or failure caused the state or its residents harm, including financial harm of more than $100. Specifically, the state government may sue the federal government over adecision to release a non-U.S. national from custody;failure to fulfill requirements relating to inspecting individuals seeking admission into the United States, including requirements related to asylum interviews;failure to fulfill a requirement to stop issuing visas to nationals of a country that unreasonably denies or delays acceptance of nationals of that country;violation of limitations on immigration parole, such as the requirement that parole be granted only on a case-by-case basis; orfailure to detain an individual who has been ordered removed from the United States.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB504

Introduced
2/10/25  
High Rise Fire Sprinkler Incentive Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB509

Introduced
2/11/25  
Future Logging Careers Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB510

Introduced
2/11/25  
Financing Our Energy Future Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB520

Introduced
2/11/25  
Supporting the Abused by Learning Options to Navigate Survivor Stories Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB522

Introduced
2/11/25  
Credit Union Board Modernization Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB531

Introduced
2/11/25  
American Apprenticeship Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB547

Introduced
2/12/25  
Train More Nurses Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB554

Introduced
2/12/25  
United States-Israel Defense Partnership Act of 2025